GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: 17-ethynyl-5-androstene-3,7,17-triol | HE-3286 | HE3286 | NE-3107 | NE3107
Compound class:
Synthetic organic
Comment: Bezisterim (NE3107 and formerly HE3286) is a synthetic, orally bioavailable analogue of the adrenal sterol metabolite androstenetriol. It can cross the blood-brain barrier. It has proposed anti-inflammatory and insulin-sensitising activities, which may be beneficial in treating the pathophysiology or symptom development in degenerative brain diseases such as Parkinson's and Alzheimer's, which are associated with chronic low-grade inflammation. The molecular target(s) of bezisterim are not fully resolved. Its anti-inflammatory and insulin-sensitising biological activities likely include modulation of pathways and networks that involve LDL receptor related protein 1 (Lrp1), Mapk3 (ERK1) and Mapk1 (ERK2) [8].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(3S,7R,8R,9S,10R,13S,14S,17R)-17-ethynyl-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,7,17-triol |
International Nonproprietary Names ![]() |
|
INN number | INN |
12493 | bezisterim |
Synonyms ![]() |
17-ethynyl-5-androstene-3,7,17-triol | HE-3286 | HE3286 | NE-3107 | NE3107 |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL4297284 |
DrugBank Ligand | DB05212 |
PubChem CID | 16739648 |
Search Google for chemical match using the InChIKey | JJKOQZHWYLMASZ-FJWDNACWSA-N |
Search Google for chemicals with the same backbone | JJKOQZHWYLMASZ |
Search PubMed clinical trials | bezisterim |
Search PubMed titles | bezisterim |
Search PubMed titles/abstracts | bezisterim |
UniChem Compound Search for chemical match using the InChIKey | JJKOQZHWYLMASZ-FJWDNACWSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JJKOQZHWYLMASZ-FJWDNACWSA-N |